Member Info for tkevin

I thought that was a really good presentation. Seemed honest.

Posh97. Not hard to find if you try. Here is a liquid kit used at UCL I found on YouTube .. The first 5 minutes is manual isolation of the RNA which could be done on the Beckman Biomek machine for Genedrive. Then the person does lots of liquid mixing from 5 minutes to 7 minutes which we don’t do. At the end, you have to programme the PCR reader which everyone has to do. Genedrive test is really more straightforward.

https://youtu.be/5f_wieig4iQ

https://www.linkedin.com/posts/genedrive-plc_genedrive-96-sars-cov-2-kit-product-training-activity-6697500819522236416-Kup3

what COVID AIM stock inst down 50% over the past 2 months? can it be that every company in incompetent or could it be the average patient PI can only wait 5 days for an RNS?

Look at NCYT SP over the past 3 months. NO idea why any short term investor points to them as a model of execution impacting SP. Problem is all the PIs claiming that they are investors in the company clearly aren't, as you wouldn't be ****ting all over a company you believed in. And if you don't believe in it, sell and move your money elsewhere. If you're coming to LSE boards for advice and guidance and not just entertainment, you should just go to your local petrol station and read the toilet wall. Lots of good stuff ,equally informative, on there too.

Dangermouse . In at 30p and so tripled you money. I can see why you’re frustrated. You need a bit of perspective in your life mate.

The Market Abuse Regulations regulations say news should be released as soon as possible/as it happens, not 7am. It remains industry practise to do a morning release as it then gets picked up in the daily news feed and investors are most likely to see it. There is nothing wrong with dropping and RNS mid day and in many cases its the right thing to do.

Beamer / Bladder / TR - they said in an RNS that is was subject to orderly disposal. If its forward sold then you're saying they issues an RNS just yesterday that wasn't true. Given that they are legally responsible for what they say, and you're just some anonymous posters that can post whatever you like, who would be better to believe - you or the company? You have no additional factual insight at all in what you post.

Bladder - RNS says "5m shares subject to orderly market disposal" and you say "may have been forward sold ". Are you not able to read because these things are opposites.

M300 - This is the problem with investors here - absolute muppets when it comes to understanding anything about reality and that’s why you’re going to be disappointed. Diagnostics are heavily regulated products and are medical devices - like pacemakers. Do you want a pacemaker company “adjusting things quickly” Or would you want them to undergo proper clinical trials of changes, make sure they’re safe, and submit to regulators to approve? Takes a year....
It’s clear listening to Sir Al that he hasn’t got a clue about diagnostics, and why would he? He’s in oncology. But the interest in Avacta is, whether you like it or not, all driven off COVID. So, you have a bright academic running a company with no idea about diagnostics, investors with no idea about diagnostics... I’m sure it will all end just fine...

Share price was 18p. That’s not on a map.

My negative posts are mainly just Avacta, because its an obvious scam that is playing out exactly like I said it would. Dither and Delay because the COVID test wont work because they will never be sensitive enough. PI are being taken advantage of because they believe what the company is telling them, but basic science and 15 minutes reading a couple of scholarly papers on Affimers (of wait, they're arent any!) will make that obvious.

Goes from a market cap of £10M to £300M in 3 months and doesn't want to raise expectations? Could you understate the problem more?
SP rise has all been due to COVID and he didn't seem to care so much about it. From the equity raise, 75% of that isn't going into COVID, which was the clearest sign ever he doesn't expect Affimers to work,but he's using the PR to fund his pet projects. If Affimers were going to light the world on fire, why raise funds? It also came across that he doesnt really know what it takes to make a diagnostic product, and investors that think he does, don't know either. He said that some of the money being raise was to hire senior regulatory and senior commercial people - ie the people that know what it takes to make a diagnostic product. Then he arrogantly said there is no reason why the regulatory people wouldn't approve it quickly.... Oh dear, a car crash. He came across as a nice scientist clueless about diagnostics, and that's what most of the investors are interested in. No regulatory, no commercial - just a bunch of scientists... winging it.

finnCap is an investor in Primary Bid, so not surprising. More AIM market shenanigans of city boys lining their own pockets.

Sorry, but History will show this is a sham.
Avacta struggles to develop or commercialise anything, send out a couple of RNS about an unproven technology they call Affimers that have never been shown to work, and promise they will cure the world. Market Cap flies, and then they raise £48M, the vast majority of which is to fund the old core business that never worked either. When Affimers don’t work out, they won’t care. But is will be a long time until you hear that because it’s a self-declared CE mark, and the commercial partners (who also are AVACTAS shareholders) won’t let you know they don’t work. Unbelievable. Only AIM. The company should have much more solid evidence to justify this market cap - Many PIs going to get burned overnight when that RNS eventually comes out – or never comes out.
If you’re an investor that believes in the old core business, this has been an amazing windfall. If you’re investing for the COVID story, you’re in trouble IMO.

If their deal was with a diagnostic industry player, it might have meaning. But doing deal with someone that sells hair accessories and beach clothes isn't great IMO. And of course, they're also an investor in the company with a severe conflict and need to support the company strategy. Another proper diagnostic partner would have the know-it-all to look at product performance etc to see the likelihood of this ever working.

Go away. You made the same post on April 3 about Fujifilm. The GDR SP then was 23p.

yes. That's why there was a broker option so existing holders could get shares, and that's why there is a general meeting to approve the allocation. Aren't we over the placing discussion now?

Shockingly poor. I know this would happen, headline RNSs about sales but not translating to EBITA. They must not be able to reliably or scale the manufacture of the Covid test.

If you can only get that level of sensitivity with an instrument, the chance of getting something better without one is a bit of a prayer.